{"id": "article-25574_0", "title": "Nasopharyngeal Cancer -- Continuing Education Activity", "content": "Nasopharyngeal carcinoma is a distinct subtype of head and neck cancer. Originating in the nasopharynx, this condition presents unique characteristics that set it apart from other head and neck squamous cell carcinomas. This activity navigates through the World Health Organization's histological classification, addressing the\u00a03 subtypes of nasopharyngeal carcinoma, nasopharynx anatomy, and the fossa of Rosenmulleras the primary subsite of origin. This activity aims to broaden the understanding of nasopharyngeal carcinoma, shedding light on its association with the Epstein-Barr virus and distinguishing it from oropharyngeal cancers linked to other viruses.", "contents": "Nasopharyngeal Cancer -- Continuing Education Activity. Nasopharyngeal carcinoma is a distinct subtype of head and neck cancer. Originating in the nasopharynx, this condition presents unique characteristics that set it apart from other head and neck squamous cell carcinomas. This activity navigates through the World Health Organization's histological classification, addressing the\u00a03 subtypes of nasopharyngeal carcinoma, nasopharynx anatomy, and the fossa of Rosenmulleras the primary subsite of origin. This activity aims to broaden the understanding of nasopharyngeal carcinoma, shedding light on its association with the Epstein-Barr virus and distinguishing it from oropharyngeal cancers linked to other viruses."}
{"id": "article-25574_1", "title": "Nasopharyngeal Cancer -- Continuing Education Activity", "content": "Emphasizing the interprofessional approach, this activity underscores the collaborative role of healthcare teams in diagnosing and\u00a0caring for patients with nasopharyngeal carcinoma. By exploring the unique characteristics of NPC, healthcare professionals\u00a0are better equipped to collaborate in delivering patient-centered care and optimizing outcomes for individuals affected by this distinct form of head and neck cancer.", "contents": "Nasopharyngeal Cancer -- Continuing Education Activity. Emphasizing the interprofessional approach, this activity underscores the collaborative role of healthcare teams in diagnosing and\u00a0caring for patients with nasopharyngeal carcinoma. By exploring the unique characteristics of NPC, healthcare professionals\u00a0are better equipped to collaborate in delivering patient-centered care and optimizing outcomes for individuals affected by this distinct form of head and neck cancer."}
{"id": "article-25574_2", "title": "Nasopharyngeal Cancer -- Continuing Education Activity", "content": "Objectives: Identify the distinct histologic features of nasopharyngeal carcinoma through thorough examination and diagnostic tools. Differential nasopharyngeal carcinoma\u00a0from other head and neck cancers based on specific etiologic factors, geographical risk patterns, and unique disease spread characteristics. Implement tailored treatment plans for nasopharyngeal carcinoma, emphasizing nonsurgical approaches such as radiation therapy and incorporating chemotherapy or immunotherapy based on the disease stage. Coordinate follow-up care and surveillance strategies post-treatment, involving regular physical examinations, nasal endoscopies, and appropriate imaging to monitor disease status and manage potential long-term complications. Access free multiple choice questions on this topic.", "contents": "Nasopharyngeal Cancer -- Continuing Education Activity. Objectives: Identify the distinct histologic features of nasopharyngeal carcinoma through thorough examination and diagnostic tools. Differential nasopharyngeal carcinoma\u00a0from other head and neck cancers based on specific etiologic factors, geographical risk patterns, and unique disease spread characteristics. Implement tailored treatment plans for nasopharyngeal carcinoma, emphasizing nonsurgical approaches such as radiation therapy and incorporating chemotherapy or immunotherapy based on the disease stage. Coordinate follow-up care and surveillance strategies post-treatment, involving regular physical examinations, nasal endoscopies, and appropriate imaging to monitor disease status and manage potential long-term complications. Access free multiple choice questions on this topic."}
{"id": "article-25574_3", "title": "Nasopharyngeal Cancer -- Introduction", "content": "The pharynx is\u00a0a tubular structure that connects the nose to the trachea. The upper portion of the pharynx, known as the nasopharynx,\u00a0is surrounded by various structures.\u00a0Anteriorly, the posterior choanae of the nasal cavity borders it. Posteriorly, it is enclosed by the mucosa overlying the superior pharyngeal constrictor. Laterally, it is defined by the fossae of Rosenmuller, eustachian tube orifices, and tori tubarius. Superiorly, it is constrained by the sphenoid, and inferiorly, it is connected\u00a0to the soft palate.", "contents": "Nasopharyngeal Cancer -- Introduction. The pharynx is\u00a0a tubular structure that connects the nose to the trachea. The upper portion of the pharynx, known as the nasopharynx,\u00a0is surrounded by various structures.\u00a0Anteriorly, the posterior choanae of the nasal cavity borders it. Posteriorly, it is enclosed by the mucosa overlying the superior pharyngeal constrictor. Laterally, it is defined by the fossae of Rosenmuller, eustachian tube orifices, and tori tubarius. Superiorly, it is constrained by the sphenoid, and inferiorly, it is connected\u00a0to the soft palate."}
{"id": "article-25574_4", "title": "Nasopharyngeal Cancer -- Introduction", "content": "Cancers arising from this area are\u00a0most commonly\u00a0squamous cell carcinoma. These cancers may\u00a0exhibit\u00a0distinctive behaviors compared to other\u00a0head and neck squamous cell carcinomas and have unique risk and etiologic factors. The most common\u00a0subsite of origin is the fossa of Rosenmuller, accounting for 50% of nasopharyngeal carcinomas. [1]", "contents": "Nasopharyngeal Cancer -- Introduction. Cancers arising from this area are\u00a0most commonly\u00a0squamous cell carcinoma. These cancers may\u00a0exhibit\u00a0distinctive behaviors compared to other\u00a0head and neck squamous cell carcinomas and have unique risk and etiologic factors. The most common\u00a0subsite of origin is the fossa of Rosenmuller, accounting for 50% of nasopharyngeal carcinomas. [1]"}
{"id": "article-25574_5", "title": "Nasopharyngeal Cancer -- Introduction", "content": "There are distinct geographic and ethnic risk factors for nasopharyngeal carcinoma. In Asia, mainly China, there is a high\u00a0incidence of disease. Having Chinese ancestry is an independent risk factor regardless of residence location. [2] A high incidence of nasopharyngeal cancer has also been noted in those of Native Alaskan ancestry. [3]", "contents": "Nasopharyngeal Cancer -- Introduction. There are distinct geographic and ethnic risk factors for nasopharyngeal carcinoma. In Asia, mainly China, there is a high\u00a0incidence of disease. Having Chinese ancestry is an independent risk factor regardless of residence location. [2] A high incidence of nasopharyngeal cancer has also been noted in those of Native Alaskan ancestry. [3]"}
{"id": "article-25574_6", "title": "Nasopharyngeal Cancer -- Introduction", "content": "Most cases in areas with a high disease incidence are related to Epstein-Barr virus (EBV) infection. However, the near-ubiquity of EBV in the global population makes specific viral etiologic pathways challenging to understand. [4] Viral oncogenes LMP-1 , LMP-2 , and EBNA1 have been\u00a0demonstrated to play an important role. [5] Although human papillomavirus (HPV)-related\u00a0nasopharyngeal cancers\u00a0have also been reported, no clear association has been established.", "contents": "Nasopharyngeal Cancer -- Introduction. Most cases in areas with a high disease incidence are related to Epstein-Barr virus (EBV) infection. However, the near-ubiquity of EBV in the global population makes specific viral etiologic pathways challenging to understand. [4] Viral oncogenes LMP-1 , LMP-2 , and EBNA1 have been\u00a0demonstrated to play an important role. [5] Although human papillomavirus (HPV)-related\u00a0nasopharyngeal cancers\u00a0have also been reported, no clear association has been established."}
{"id": "article-25574_7", "title": "Nasopharyngeal Cancer -- Introduction", "content": "The clinical behavior of\u00a0nasopharyngeal cancers varies depending on their histological subtype. The World Health Organization (WHO) has classified nasopharyngeal carcinoma into\u00a03 subtypes based on histology. Type 1 is keratinizing squamous cell carcinoma, associated with EBV infection in around 70% to 80% of cases. [6] Type 2 is differentiated nonkeratinizing carcinoma, and type 3 is undifferentiated carcinoma, the most common\u00a0subtype of\u00a0nasopharyngeal cancer. [7] The latter 2 types are also most responsive to treatment. Almost all cases of type 2 and type 3 are related to EBV and occur in areas where EBV is endemic.\u00a0Nasopharyngeal cancer\u00a0with basaloid features is a newer, rarer histologic category known to behave aggressively. [8]", "contents": "Nasopharyngeal Cancer -- Introduction. The clinical behavior of\u00a0nasopharyngeal cancers varies depending on their histological subtype. The World Health Organization (WHO) has classified nasopharyngeal carcinoma into\u00a03 subtypes based on histology. Type 1 is keratinizing squamous cell carcinoma, associated with EBV infection in around 70% to 80% of cases. [6] Type 2 is differentiated nonkeratinizing carcinoma, and type 3 is undifferentiated carcinoma, the most common\u00a0subtype of\u00a0nasopharyngeal cancer. [7] The latter 2 types are also most responsive to treatment. Almost all cases of type 2 and type 3 are related to EBV and occur in areas where EBV is endemic.\u00a0Nasopharyngeal cancer\u00a0with basaloid features is a newer, rarer histologic category known to behave aggressively. [8]"}
{"id": "article-25574_8", "title": "Nasopharyngeal Cancer -- Introduction", "content": "Treatment is determined based on stage and\u00a0is typically nonsurgical owing to technical reasons. Radiation therapy may be used alone for early (stage I and II) disease, while chemotherapy may be added for stage III or IV disease. Genetic markers, including some viral-related surface proteins, may also be used as targets for immunotherapy. [9]", "contents": "Nasopharyngeal Cancer -- Introduction. Treatment is determined based on stage and\u00a0is typically nonsurgical owing to technical reasons. Radiation therapy may be used alone for early (stage I and II) disease, while chemotherapy may be added for stage III or IV disease. Genetic markers, including some viral-related surface proteins, may also be used as targets for immunotherapy. [9]"}
{"id": "article-25574_9", "title": "Nasopharyngeal Cancer -- Introduction", "content": "Over the past decade, mortality related to\u00a0nasopharyngeal cancers\u00a0has\u00a0seen improvement attributed\u00a0to early detection and advances in treatment. [10] [11] [12] This progress underscores the importance of ongoing research and innovations in nasopharyngeal cancer management.", "contents": "Nasopharyngeal Cancer -- Introduction. Over the past decade, mortality related to\u00a0nasopharyngeal cancers\u00a0has\u00a0seen improvement attributed\u00a0to early detection and advances in treatment. [10] [11] [12] This progress underscores the importance of ongoing research and innovations in nasopharyngeal cancer management."}
{"id": "article-25574_10", "title": "Nasopharyngeal Cancer -- Etiology", "content": "The precise etiology of nasopharyngeal carcinoma is complex and not\u00a0fully understood. Carcinogenesis is most likely due to hereditary genetics, environmental factors, and viral factors. In areas where EBV is not endemic, such as the US, smoking and alcohol\u00a0have been\u00a0identified\u00a0as\u00a0risk factors for nasopharyngeal carcinoma. Conversely, in EBV-endemic areas, this association does not hold. [13] This\u00a0difference is\u00a0reflected by WHO type 1 tumors, which are more variable in etiology and unrelated to EBV. In comparison, the association between EBV and WHO type 2 and 3 tumors is definitive. [14]", "contents": "Nasopharyngeal Cancer -- Etiology. The precise etiology of nasopharyngeal carcinoma is complex and not\u00a0fully understood. Carcinogenesis is most likely due to hereditary genetics, environmental factors, and viral factors. In areas where EBV is not endemic, such as the US, smoking and alcohol\u00a0have been\u00a0identified\u00a0as\u00a0risk factors for nasopharyngeal carcinoma. Conversely, in EBV-endemic areas, this association does not hold. [13] This\u00a0difference is\u00a0reflected by WHO type 1 tumors, which are more variable in etiology and unrelated to EBV. In comparison, the association between EBV and WHO type 2 and 3 tumors is definitive. [14]"}
{"id": "article-25574_11", "title": "Nasopharyngeal Cancer -- Etiology", "content": "Other risk factors include Asian ancestry, particularly Chinese ancestry, remaining an independent risk factor even outside of Asia. [15] This theory explains the increased nasopharyngeal carcinoma\u00a0risk in those of Native Alaskan ancestry, as common ancestral genetic links have been described utilizing D4h mitochondrial DNA analysis. [16] Dietary risk factors, such as diets high in preserved foods containing nitrosamines (particularly salted preserved fish), have also been postulated to confer additional risk of nasopharyngeal carcinoma. [17]", "contents": "Nasopharyngeal Cancer -- Etiology. Other risk factors include Asian ancestry, particularly Chinese ancestry, remaining an independent risk factor even outside of Asia. [15] This theory explains the increased nasopharyngeal carcinoma\u00a0risk in those of Native Alaskan ancestry, as common ancestral genetic links have been described utilizing D4h mitochondrial DNA analysis. [16] Dietary risk factors, such as diets high in preserved foods containing nitrosamines (particularly salted preserved fish), have also been postulated to confer additional risk of nasopharyngeal carcinoma. [17]"}
{"id": "article-25574_12", "title": "Nasopharyngeal Cancer -- Etiology", "content": "Some epidemiologic studies establish family\u00a0clusters of\u00a0nasopharyngeal cancer in endemic and nonendemic areas, suggesting ancestral genetics and environmental factors likely play an etiologic role. [18] [19] In some endemic areas worldwide, circulating EBV DNA is utilized for screening and disease surveillance. High circulating levels of EBV DNA are associated with poorer treatment response and higher rates of distant metastasis and mortality. [20] The prognostic value of circulating EBV titers has not been extensively studied, but persistently elevated EBV titers after treatment have been described as a powerful poor prognostic factor for overall survival. [21] [22]", "contents": "Nasopharyngeal Cancer -- Etiology. Some epidemiologic studies establish family\u00a0clusters of\u00a0nasopharyngeal cancer in endemic and nonendemic areas, suggesting ancestral genetics and environmental factors likely play an etiologic role. [18] [19] In some endemic areas worldwide, circulating EBV DNA is utilized for screening and disease surveillance. High circulating levels of EBV DNA are associated with poorer treatment response and higher rates of distant metastasis and mortality. [20] The prognostic value of circulating EBV titers has not been extensively studied, but persistently elevated EBV titers after treatment have been described as a powerful poor prognostic factor for overall survival. [21] [22]"}
{"id": "article-25574_13", "title": "Nasopharyngeal Cancer -- Epidemiology", "content": "There are significant geographic variations in the epidemiology of nasopharyngeal carcinoma. In nonendemic areas,\u00a0such as\u00a0the\u00a0Americas and Europe,\u00a0nasopharyngeal cancer is rare, with less than 1 case per 100,000 people. [23] The incidence is much higher, reaching up to\u00a021 cases per 100,000 people in\u00a0certain parts of China, where nasopharyngeal carcinoma accounts for 18% of all cancers. [24] In Asia,\u00a0nasopharyngeal carcinoma is a disease of middle age, with patients presenting in the 4th through 6th decades of life. [25] In Africa, another area with\u00a0endemic EBV infection, the majority of cases are\u00a0observed in children. [26] [27]", "contents": "Nasopharyngeal Cancer -- Epidemiology. There are significant geographic variations in the epidemiology of nasopharyngeal carcinoma. In nonendemic areas,\u00a0such as\u00a0the\u00a0Americas and Europe,\u00a0nasopharyngeal cancer is rare, with less than 1 case per 100,000 people. [23] The incidence is much higher, reaching up to\u00a021 cases per 100,000 people in\u00a0certain parts of China, where nasopharyngeal carcinoma accounts for 18% of all cancers. [24] In Asia,\u00a0nasopharyngeal carcinoma is a disease of middle age, with patients presenting in the 4th through 6th decades of life. [25] In Africa, another area with\u00a0endemic EBV infection, the majority of cases are\u00a0observed in children. [26] [27]"}
{"id": "article-25574_14", "title": "Nasopharyngeal Cancer -- Epidemiology", "content": "Nonendemic areas\u00a0regions, such as the Americas and Europe,\u00a0exhibit\u00a0a bimodal age distribution. The first peak occurs in the late teenage years,\u00a0and\u00a0the second peak\u00a0appears in the\u00a0sixth to seventh\u00a0decade of life. [28] Gender discrepancies\u00a0exist\u00a0in the risk of developing nasopharyngeal carcinoma and in nasopharyngeal carcinoma-specific\u00a0mortality. Males are\u00a0traditionally\u00a0reported to have\u00a0a 2.75-fold higher risk of developing nasopharyngeal carcinoma and a 3.25-fold greater risk of dying from\u00a0nasopharyngeal carcinoma\u00a0compared to females. [29] It remains unclear\u00a0whether this additional risk and mortality\u00a0are related to differing tobacco use patterns among men and women, and\u00a0much of the data originates from China. In this endemic area, tobacco smoking is much more common among men than women. Some of these discrepancies have also been age-dependent, with risk and mortality nearly equivalent in those over 55 years in one Chinese study. [30]", "contents": "Nasopharyngeal Cancer -- Epidemiology. Nonendemic areas\u00a0regions, such as the Americas and Europe,\u00a0exhibit\u00a0a bimodal age distribution. The first peak occurs in the late teenage years,\u00a0and\u00a0the second peak\u00a0appears in the\u00a0sixth to seventh\u00a0decade of life. [28] Gender discrepancies\u00a0exist\u00a0in the risk of developing nasopharyngeal carcinoma and in nasopharyngeal carcinoma-specific\u00a0mortality. Males are\u00a0traditionally\u00a0reported to have\u00a0a 2.75-fold higher risk of developing nasopharyngeal carcinoma and a 3.25-fold greater risk of dying from\u00a0nasopharyngeal carcinoma\u00a0compared to females. [29] It remains unclear\u00a0whether this additional risk and mortality\u00a0are related to differing tobacco use patterns among men and women, and\u00a0much of the data originates from China. In this endemic area, tobacco smoking is much more common among men than women. Some of these discrepancies have also been age-dependent, with risk and mortality nearly equivalent in those over 55 years in one Chinese study. [30]"}
{"id": "article-25574_15", "title": "Nasopharyngeal Cancer -- Pathophysiology", "content": "Nasopharyngeal carcinoma stands out as a distinct subtype of head and neck cancer with\u00a0a pathogenesis\u00a0that is equally\u00a0unique. Most\u00a0nasopharyngeal carcinoma cases\u00a0are EBV-related, and research regarding pathogenesis and malignant transformation in\u00a0nasopharyngeal carcinoma\u00a0has focused\u00a0on various viral gene products, along with host genetic factors that may\u00a0increase susceptibility to EBV infection. [31]", "contents": "Nasopharyngeal Cancer -- Pathophysiology. Nasopharyngeal carcinoma stands out as a distinct subtype of head and neck cancer with\u00a0a pathogenesis\u00a0that is equally\u00a0unique. Most\u00a0nasopharyngeal carcinoma cases\u00a0are EBV-related, and research regarding pathogenesis and malignant transformation in\u00a0nasopharyngeal carcinoma\u00a0has focused\u00a0on various viral gene products, along with host genetic factors that may\u00a0increase susceptibility to EBV infection. [31]"}
{"id": "article-25574_16", "title": "Nasopharyngeal Cancer -- Pathophysiology", "content": "In endemic areas, the majority of nasopharyngeal carcinoma tumor cells and precancerous lesions have been found to contain isolated EBV DNA, reinforcing causative association. Additionally,\u00a0a strong correlation exists with human leukocyte antigen (HLA) mutations that\u00a0increase susceptibility to malignant transformation, and\u00a0these mutations\u00a0are more\u00a0prevalent among\u00a0individuals of Chinese and other Southeast Asian ancestries. [32] The most potent risk factors for nasopharyngeal carcinoma development have been identified as major histocompatibility complex (MHC) I gene variants. [33]", "contents": "Nasopharyngeal Cancer -- Pathophysiology. In endemic areas, the majority of nasopharyngeal carcinoma tumor cells and precancerous lesions have been found to contain isolated EBV DNA, reinforcing causative association. Additionally,\u00a0a strong correlation exists with human leukocyte antigen (HLA) mutations that\u00a0increase susceptibility to malignant transformation, and\u00a0these mutations\u00a0are more\u00a0prevalent among\u00a0individuals of Chinese and other Southeast Asian ancestries. [32] The most potent risk factors for nasopharyngeal carcinoma development have been identified as major histocompatibility complex (MHC) I gene variants. [33]"}
{"id": "article-25574_17", "title": "Nasopharyngeal Cancer -- Pathophysiology", "content": "The most widely accepted theory of tumorigenesis in EBV-related\u00a0nasopharyngeal carcinoma (given EBV's implication in\u00a0various malignancies)\u00a0suggests\u00a0a clonal malignancy originating from a single, latently infected progenitor cell in the lymphocyte-rich nasopharyngeal mucosa. [34] A\u00a0hallmark of EBV-related\u00a0nasopharyngeal carcinoma is the necessity\u00a0for multiple genetic abnormalities\u00a0induced by latent viral genes for oncogenesis. Specifically, EBNA, EBER1, and EBER2 have been extensively studied, [35] [36] with LMP1 emerging as a key oncoprotein. LMP1 is\u00a0a potent\u00a0signal activator for\u00a0various pathways, including JNK/AP1, P13K, MAPK, and NF-\u03baB. [37] [38]", "contents": "Nasopharyngeal Cancer -- Pathophysiology. The most widely accepted theory of tumorigenesis in EBV-related\u00a0nasopharyngeal carcinoma (given EBV's implication in\u00a0various malignancies)\u00a0suggests\u00a0a clonal malignancy originating from a single, latently infected progenitor cell in the lymphocyte-rich nasopharyngeal mucosa. [34] A\u00a0hallmark of EBV-related\u00a0nasopharyngeal carcinoma is the necessity\u00a0for multiple genetic abnormalities\u00a0induced by latent viral genes for oncogenesis. Specifically, EBNA, EBER1, and EBER2 have been extensively studied, [35] [36] with LMP1 emerging as a key oncoprotein. LMP1 is\u00a0a potent\u00a0signal activator for\u00a0various pathways, including JNK/AP1, P13K, MAPK, and NF-\u03baB. [37] [38]"}
{"id": "article-25574_18", "title": "Nasopharyngeal Cancer -- Histopathology", "content": "Nasopharyngeal carcinoma exhibits distinctive histopathological features. The WHO classifies\u00a0nasopharyngeal carcinoma into\u00a03 main subtypes based on histology:", "contents": "Nasopharyngeal Cancer -- Histopathology. Nasopharyngeal carcinoma exhibits distinctive histopathological features. The WHO classifies\u00a0nasopharyngeal carcinoma into\u00a03 main subtypes based on histology:"}
{"id": "article-25574_19", "title": "Nasopharyngeal Cancer -- Histopathology", "content": "Type 1. Keratinizing : Histologically indistinguishable from keratinizing\u00a0squamous cell carcinoma\u00a0in\u00a0other body sites. It exhibits apparent squamous differentiation with prominent intracellular bridges and variable keratinization, including keratin pearls. Consequently, it can be graded as well, moderate, or poorly differentiated\u00a0based\u00a0on the degree of keratinization. [39]", "contents": "Nasopharyngeal Cancer -- Histopathology. Type 1. Keratinizing : Histologically indistinguishable from keratinizing\u00a0squamous cell carcinoma\u00a0in\u00a0other body sites. It exhibits apparent squamous differentiation with prominent intracellular bridges and variable keratinization, including keratin pearls. Consequently, it can be graded as well, moderate, or poorly differentiated\u00a0based\u00a0on the degree of keratinization. [39]"}
{"id": "article-25574_20", "title": "Nasopharyngeal Cancer -- Histopathology", "content": "Type 2. Nonkeratinizing (differentiated) : Characterized by cords or trabeculae of interconnected cells with well-defined borders and little to no keratinization. The presence or absence of intracellular bridges may vary, and the tumor may exhibit\u00a0a resemblance to urothelial carcinoma. Typically, there is no desmoplastic response to the cancer, although the stroma may display a nonneoplastic lymphoplasmacytic infiltrate.", "contents": "Nasopharyngeal Cancer -- Histopathology. Type 2. Nonkeratinizing (differentiated) : Characterized by cords or trabeculae of interconnected cells with well-defined borders and little to no keratinization. The presence or absence of intracellular bridges may vary, and the tumor may exhibit\u00a0a resemblance to urothelial carcinoma. Typically, there is no desmoplastic response to the cancer, although the stroma may display a nonneoplastic lymphoplasmacytic infiltrate."}
{"id": "article-25574_21", "title": "Nasopharyngeal Cancer -- Histopathology", "content": "Within the same tumor, there may exist both differentiated and nondifferentiated loci.\u00a0The classification of the tumor should be\u00a0according\u00a0to the dominant component. This classification of degree of differentiation is optional, as it does not carry any prognostic significance. Type 3. Nonkeratinizing (undifferentiated) : Displays\u00a01 of\u00a02 predominant patterns on hematoxylin and eosin (H&E) staining, though these patterns do not appear to affect prognosis: [40] Regaud pattern: Cohesive cells with indistinct margins arranged in a syncytial pattern Schmincke pattern: Noncohesive cells with a diffuse cellular infiltrate, resembling non-Hodgkin lymphoma", "contents": "Nasopharyngeal Cancer -- Histopathology. Within the same tumor, there may exist both differentiated and nondifferentiated loci.\u00a0The classification of the tumor should be\u00a0according\u00a0to the dominant component. This classification of degree of differentiation is optional, as it does not carry any prognostic significance. Type 3. Nonkeratinizing (undifferentiated) : Displays\u00a01 of\u00a02 predominant patterns on hematoxylin and eosin (H&E) staining, though these patterns do not appear to affect prognosis: [40] Regaud pattern: Cohesive cells with indistinct margins arranged in a syncytial pattern Schmincke pattern: Noncohesive cells with a diffuse cellular infiltrate, resembling non-Hodgkin lymphoma"}
{"id": "article-25574_22", "title": "Nasopharyngeal Cancer -- Histopathology", "content": "The cells in this subtype typically\u00a0exhibit round nuclei with prominent nucleoli. There is an absence of keratinization, while increased mitoses and apoptosis are universally present. However, necrosis is infrequent.\u00a0Additionally, a nonneoplastic lymphoplasmacytic infiltrate is often observed in the surrounding tissue.", "contents": "Nasopharyngeal Cancer -- Histopathology. The cells in this subtype typically\u00a0exhibit round nuclei with prominent nucleoli. There is an absence of keratinization, while increased mitoses and apoptosis are universally present. However, necrosis is infrequent.\u00a0Additionally, a nonneoplastic lymphoplasmacytic infiltrate is often observed in the surrounding tissue."}
{"id": "article-25574_23", "title": "Nasopharyngeal Cancer -- Histopathology", "content": "Immunohistochemistry is crucial in characterizing nasopharyngeal carcinoma by detecting specific protein markers. Positive staining is observed for the following markers in nasopharyngeal carcinoma: [41] EBV latent membrane Protein High molecular weight keratin Pancytokeratin p63 p40 Negative staining is noted for the following markers: CK20 CD45 S100 HMB45 MelanA Desmin Myoglobin Myogenin CK7 (may occasionally show positivity)", "contents": "Nasopharyngeal Cancer -- Histopathology. Immunohistochemistry is crucial in characterizing nasopharyngeal carcinoma by detecting specific protein markers. Positive staining is observed for the following markers in nasopharyngeal carcinoma: [41] EBV latent membrane Protein High molecular weight keratin Pancytokeratin p63 p40 Negative staining is noted for the following markers: CK20 CD45 S100 HMB45 MelanA Desmin Myoglobin Myogenin CK7 (may occasionally show positivity)"}
{"id": "article-25574_24", "title": "Nasopharyngeal Cancer -- Histopathology", "content": "EBV DNA is detected in 75% to 100% of nasopharyngeal carcinoma cases using PCR or FISH. [42] This high detection rate underscores the significance of EBV DNA testing in confirming the presence of\u00a0EBV in nasopharyngeal carcinoma, aiding in accurate diagnosis and treatment planning.", "contents": "Nasopharyngeal Cancer -- Histopathology. EBV DNA is detected in 75% to 100% of nasopharyngeal carcinoma cases using PCR or FISH. [42] This high detection rate underscores the significance of EBV DNA testing in confirming the presence of\u00a0EBV in nasopharyngeal carcinoma, aiding in accurate diagnosis and treatment planning."}
{"id": "article-25574_25", "title": "Nasopharyngeal Cancer -- History and Physical", "content": "Symptoms of\u00a0nasopharyngeal cancer\u00a0are\u00a0stage-dependent, and most cases present at an advanced stage with a palpable neck nodal metastasis. [43] A solitary, painless, incidentally noted neck mass is\u00a0a common initial sign\u00a0and symptom in\u00a0various head and neck cancers. In adults, a new neck mass that has persisted for over 2 weeks should be presumed malignant until proven otherwise.\u00a0Inquiry into the onset of the neck mass, its identification method, and any antecedent upper respiratory or dental infections are crucial. Additionally, changes in the mass size and the presence of any other neck masses should be addressed.", "contents": "Nasopharyngeal Cancer -- History and Physical. Symptoms of\u00a0nasopharyngeal cancer\u00a0are\u00a0stage-dependent, and most cases present at an advanced stage with a palpable neck nodal metastasis. [43] A solitary, painless, incidentally noted neck mass is\u00a0a common initial sign\u00a0and symptom in\u00a0various head and neck cancers. In adults, a new neck mass that has persisted for over 2 weeks should be presumed malignant until proven otherwise.\u00a0Inquiry into the onset of the neck mass, its identification method, and any antecedent upper respiratory or dental infections are crucial. Additionally, changes in the mass size and the presence of any other neck masses should be addressed."}
{"id": "article-25574_26", "title": "Nasopharyngeal Cancer -- History and Physical", "content": "Associated symptoms such as hoarseness or voice changes, dysphagia or odynophagia, otalgia, nasal obstruction (unilateral\u00a0versus bilateral), epistaxis, hemoptysis, hematemesis, vision changes, headache or facial pain,\u00a0and persistent rhinorrhea should be carefully investigated.\u00a0Gathering a comprehensive social\u00a0history, including information on tobacco and alcohol use, prolonged sun exposure (occupational or recreational), sunscreen use, and occupational history, is essential. Family and ethnic background, particularly in individuals of Asian ancestry, should be obtained. A thorough past medical history, including any previous head and neck cancers, skin cancers, or immunosuppression, should also be documented.", "contents": "Nasopharyngeal Cancer -- History and Physical. Associated symptoms such as hoarseness or voice changes, dysphagia or odynophagia, otalgia, nasal obstruction (unilateral\u00a0versus bilateral), epistaxis, hemoptysis, hematemesis, vision changes, headache or facial pain,\u00a0and persistent rhinorrhea should be carefully investigated.\u00a0Gathering a comprehensive social\u00a0history, including information on tobacco and alcohol use, prolonged sun exposure (occupational or recreational), sunscreen use, and occupational history, is essential. Family and ethnic background, particularly in individuals of Asian ancestry, should be obtained. A thorough past medical history, including any previous head and neck cancers, skin cancers, or immunosuppression, should also be documented."}
{"id": "article-25574_27", "title": "Nasopharyngeal Cancer -- History and Physical", "content": "A comprehensive physical examination of the head and neck is imperative.\u00a0The skin and scalp should be examined for visible or palpable lesions, and\u00a0investigation into encountered scars is essential to determine whether they represent previously excised malignant or premalignant lesions.", "contents": "Nasopharyngeal Cancer -- History and Physical. A comprehensive physical examination of the head and neck is imperative.\u00a0The skin and scalp should be examined for visible or palpable lesions, and\u00a0investigation into encountered scars is essential to determine whether they represent previously excised malignant or premalignant lesions."}
{"id": "article-25574_28", "title": "Nasopharyngeal Cancer -- History and Physical", "content": "The otologic examination is necessary to assess the middle ears for effusion, with particular attention to unilateral effusion, as it may indicate nasopharyngeal obstruction in adults. Anterior rhinoscopy\u00a0is crucial for detecting\u00a0visible lesions before and after administering topical decongestant. Nasal endoscopy\u00a0is essential for a\u00a0thorough evaluation of the nasopharynx. While some adenoid tissue may persist into adulthood, the presence of prominent or asymmetric adenoids\u00a0in adults is a cause for concern.", "contents": "Nasopharyngeal Cancer -- History and Physical. The otologic examination is necessary to assess the middle ears for effusion, with particular attention to unilateral effusion, as it may indicate nasopharyngeal obstruction in adults. Anterior rhinoscopy\u00a0is crucial for detecting\u00a0visible lesions before and after administering topical decongestant. Nasal endoscopy\u00a0is essential for a\u00a0thorough evaluation of the nasopharynx. While some adenoid tissue may persist into adulthood, the presence of prominent or asymmetric adenoids\u00a0in adults is a cause for concern."}
{"id": "article-25574_29", "title": "Nasopharyngeal Cancer -- History and Physical", "content": "An oral cavity and oropharyngeal examination should focus\u00a0on mucosal lesions, dental health, and palpation of the tongue, base of the tongue, and floor of the mouth. Flexible laryngoscopy\u00a0is necessary to examine the tongue base, oropharynx, and hypopharynx thoroughly. Any masses or lymphadenopathy, thyroid nodules, and stridor or hoarseness should be carefully noted during the neck examination. A cranial nerve examination is mandatory,\u00a0particularly in identifying deficits or asymmetries.", "contents": "Nasopharyngeal Cancer -- History and Physical. An oral cavity and oropharyngeal examination should focus\u00a0on mucosal lesions, dental health, and palpation of the tongue, base of the tongue, and floor of the mouth. Flexible laryngoscopy\u00a0is necessary to examine the tongue base, oropharynx, and hypopharynx thoroughly. Any masses or lymphadenopathy, thyroid nodules, and stridor or hoarseness should be carefully noted during the neck examination. A cranial nerve examination is mandatory,\u00a0particularly in identifying deficits or asymmetries."}
{"id": "article-25574_30", "title": "Nasopharyngeal Cancer -- Evaluation", "content": "A thorough history and physical examination of the head and neck are paramount, guiding all subsequent workups. If a suspicious mass is identified in the oral cavity, oropharynx, thyroid, or hypopharynx, a\u00a0computed tomography (CT) scan with intravenous (IV) contrast of the neck should be obtained.", "contents": "Nasopharyngeal Cancer -- Evaluation. A thorough history and physical examination of the head and neck are paramount, guiding all subsequent workups. If a suspicious mass is identified in the oral cavity, oropharynx, thyroid, or hypopharynx, a\u00a0computed tomography (CT) scan with intravenous (IV) contrast of the neck should be obtained."}
{"id": "article-25574_31", "title": "Nasopharyngeal Cancer -- Evaluation", "content": "The choice of subsequent imaging for a suspicious mass in the nasopharynx has been historically controversial. CT with IV contrast\u00a0has long\u00a0been the preferred\u00a0imaging modality for initial staging. CT excels in determining bony invasion and evaluating the relevant nodal basins and is often required for treatment planning in radiation therapy. [44] However, CT is less accurate in\u00a0assessing the extent of soft-tissue involvement, and\u00a0its resolution may be inadequate\u00a0for detecting extremely small tumors, where\u00a0magnetic resonance imaging\u00a0(MRI) or positron emission tomography and CT (PET-CT) can be more helpful, respectively. [45]", "contents": "Nasopharyngeal Cancer -- Evaluation. The choice of subsequent imaging for a suspicious mass in the nasopharynx has been historically controversial. CT with IV contrast\u00a0has long\u00a0been the preferred\u00a0imaging modality for initial staging. CT excels in determining bony invasion and evaluating the relevant nodal basins and is often required for treatment planning in radiation therapy. [44] However, CT is less accurate in\u00a0assessing the extent of soft-tissue involvement, and\u00a0its resolution may be inadequate\u00a0for detecting extremely small tumors, where\u00a0magnetic resonance imaging\u00a0(MRI) or positron emission tomography and CT (PET-CT) can be more helpful, respectively. [45]"}
{"id": "article-25574_32", "title": "Nasopharyngeal Cancer -- Evaluation", "content": "Practical and logistical considerations may lead to obtaining a CT scan as the first-line imaging modality today, especially where\u00a0CT is more widely available or required for insurance reasons. CT is also\u00a0chosen when patients are unable to\u00a0undergo an MRI due to implanted metal or claustrophobia.\u00a0In cases where CT is used, obtaining fine-cut (1 to 2mm) images through the nasopharynx\u00a0is crucial for optimal\u00a0evaluation of the presumed tumor and the neural foramina of the skull base. [46]", "contents": "Nasopharyngeal Cancer -- Evaluation. Practical and logistical considerations may lead to obtaining a CT scan as the first-line imaging modality today, especially where\u00a0CT is more widely available or required for insurance reasons. CT is also\u00a0chosen when patients are unable to\u00a0undergo an MRI due to implanted metal or claustrophobia.\u00a0In cases where CT is used, obtaining fine-cut (1 to 2mm) images through the nasopharynx\u00a0is crucial for optimal\u00a0evaluation of the presumed tumor and the neural foramina of the skull base. [46]"}
{"id": "article-25574_33", "title": "Nasopharyngeal Cancer -- Evaluation", "content": "MRI of the face and neck is the best\u00a0modality\u00a0for evaluating the extent of the primary tumor (T stage) with\u00a0the utmost precision. It surpasses other imaging techniques in detecting subclinical primary tumors that\u00a0might be missed on endoscopy and CT scans. [47] While CT scans also effectively assess cervical lymph nodes, MRI is\u00a0considered an acceptable\u00a0alternative. [48] However, a PET scan is strongly recommended\u00a0for evaluating metastatic disease (M stage)\u00a0due to the\u00a0tendency of nasopharyngeal cancers\u00a0to metastasize, as well as\u00a0its capability to\u00a0identify subclinical nodal metastases.", "contents": "Nasopharyngeal Cancer -- Evaluation. MRI of the face and neck is the best\u00a0modality\u00a0for evaluating the extent of the primary tumor (T stage) with\u00a0the utmost precision. It surpasses other imaging techniques in detecting subclinical primary tumors that\u00a0might be missed on endoscopy and CT scans. [47] While CT scans also effectively assess cervical lymph nodes, MRI is\u00a0considered an acceptable\u00a0alternative. [48] However, a PET scan is strongly recommended\u00a0for evaluating metastatic disease (M stage)\u00a0due to the\u00a0tendency of nasopharyngeal cancers\u00a0to metastasize, as well as\u00a0its capability to\u00a0identify subclinical nodal metastases."}
{"id": "article-25574_34", "title": "Nasopharyngeal Cancer -- Evaluation", "content": "A histologic diagnosis is\u00a0essential for accurate\u00a0staging and treatment planning. This can be effectively achieved through\u00a0an endoscopic biopsy of a nasopharyngeal mass performed under local or general anesthesia. In cases where the primary tumor is not readily evident clinically, fine needle aspiration of the\u00a0metastatic neck node can be conducted for cytology and EBV testing. An EBV-positive nodal metastasis can be safely assumed to originate from a nasopharyngeal primary, facilitating staging, prognosis, and treatment decisions, even without a visible primary lesion. [49] [50] [51]", "contents": "Nasopharyngeal Cancer -- Evaluation. A histologic diagnosis is\u00a0essential for accurate\u00a0staging and treatment planning. This can be effectively achieved through\u00a0an endoscopic biopsy of a nasopharyngeal mass performed under local or general anesthesia. In cases where the primary tumor is not readily evident clinically, fine needle aspiration of the\u00a0metastatic neck node can be conducted for cytology and EBV testing. An EBV-positive nodal metastasis can be safely assumed to originate from a nasopharyngeal primary, facilitating staging, prognosis, and treatment decisions, even without a visible primary lesion. [49] [50] [51]"}
{"id": "article-25574_35", "title": "Nasopharyngeal Cancer -- Evaluation", "content": "The standard of care for these patients involves an interprofessional evaluation, typically conducted in a tumor board or\u00a0another\u00a0multidisciplinary clinic. This collaborative approach includes consultation with medical oncology, radiation oncology, surgical oncology, radiology, and pathology.", "contents": "Nasopharyngeal Cancer -- Evaluation. The standard of care for these patients involves an interprofessional evaluation, typically conducted in a tumor board or\u00a0another\u00a0multidisciplinary clinic. This collaborative approach includes consultation with medical oncology, radiation oncology, surgical oncology, radiology, and pathology."}
{"id": "article-25574_36", "title": "Nasopharyngeal Cancer -- Treatment / Management", "content": "Nonsurgical approaches are the primary mode of treatment for most nasopharyngeal cancers. The anatomical challenges posed by the nasopharynx\u00a0make surgical access difficult, and the typical late-stage presentation of\u00a0nasopharyngeal carcinoma often renders primary tumors unresectable due to the involvement of bony structures that cannot be safely removed.\u00a0Although exceptionally\u00a0rare, small primary\u00a0nasopharyngeal carcinoma cases may be considered for surgical treatment using endoscopic or transpalatal approaches, primarily documented in case-series reports. [52]", "contents": "Nasopharyngeal Cancer -- Treatment / Management. Nonsurgical approaches are the primary mode of treatment for most nasopharyngeal cancers. The anatomical challenges posed by the nasopharynx\u00a0make surgical access difficult, and the typical late-stage presentation of\u00a0nasopharyngeal carcinoma often renders primary tumors unresectable due to the involvement of bony structures that cannot be safely removed.\u00a0Although exceptionally\u00a0rare, small primary\u00a0nasopharyngeal carcinoma cases may be considered for surgical treatment using endoscopic or transpalatal approaches, primarily documented in case-series reports. [52]"}
{"id": "article-25574_37", "title": "Nasopharyngeal Cancer -- Treatment / Management", "content": "In instances of local failure after primary chemo and radiation therapy, nasopharyngectomy (either endoscopic\u00a0or open) has been employed. Notably, the most extensive series reported more than 80% local control at\u00a02 years postoperatively. [53] However, it is essential to recognize that surgical intervention in nasopharyngeal cancer remains a specialized and infrequently utilized option.", "contents": "Nasopharyngeal Cancer -- Treatment / Management. In instances of local failure after primary chemo and radiation therapy, nasopharyngectomy (either endoscopic\u00a0or open) has been employed. Notably, the most extensive series reported more than 80% local control at\u00a02 years postoperatively. [53] However, it is essential to recognize that surgical intervention in nasopharyngeal cancer remains a specialized and infrequently utilized option."}
{"id": "article-25574_38", "title": "Nasopharyngeal Cancer -- Treatment / Management", "content": "Nonsurgical treatment for nasopharyngeal carcinoma includes radiation therapy, chemotherapy, or a combination of modalities, depending on the stage of the tumor. Efforts should be made to enroll all patients in available clinical trials to explore innovative and potentially more effective treatment approaches. [9]", "contents": "Nasopharyngeal Cancer -- Treatment / Management. Nonsurgical treatment for nasopharyngeal carcinoma includes radiation therapy, chemotherapy, or a combination of modalities, depending on the stage of the tumor. Efforts should be made to enroll all patients in available clinical trials to explore innovative and potentially more effective treatment approaches. [9]"}
{"id": "article-25574_39", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy", "content": "Radiation therapy is the essential treatment modality for nasopharyngeal carcinoma. The introduction of intensity-modulated radiation therapy in the 1990s has\u00a0established\u00a0a new standard of care. Consensus guidelines for tumor delineation\u00a0in\u00a0nasopharyngeal carcinoma have been established to optimize\u00a0oncologic control\u00a0while minimizing toxicity to\u00a0critical surrounding structures such as the eyes, brain, middle ear, and temporomandibular joint. [54] In stage I nasopharyngeal carcinoma, radiation therapy is used as a single-modality treatment,\u00a0and chemotherapy\u00a0is added for more advanced-stage disease, as discussed later.", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy. Radiation therapy is the essential treatment modality for nasopharyngeal carcinoma. The introduction of intensity-modulated radiation therapy in the 1990s has\u00a0established\u00a0a new standard of care. Consensus guidelines for tumor delineation\u00a0in\u00a0nasopharyngeal carcinoma have been established to optimize\u00a0oncologic control\u00a0while minimizing toxicity to\u00a0critical surrounding structures such as the eyes, brain, middle ear, and temporomandibular joint. [54] In stage I nasopharyngeal carcinoma, radiation therapy is used as a single-modality treatment,\u00a0and chemotherapy\u00a0is added for more advanced-stage disease, as discussed later."}
{"id": "article-25574_40", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy", "content": "Traditionally, treatment fields for\u00a0nasopharyngeal carcinoma encompassed the entire (bilateral) nasopharynx, along with the at-risk nodal basins of the retropharynx and bilateral neck. The fossa of Rosenmuller is the most common site of origin within the nasopharynx, representing over 80% of nasopharyngeal carcinoma cases, with the tumor remaining unilateral in up to 90% of cases even as the tumor expands. [55] [56] Recognizing the potential to reduce radiation dose volumes, the deliberate exclusion of the contralateral nasopharynx and surrounding critical structures in\u00a0the NRG HN001 trial resulted in up to 62% reduction in CTV2 volume and a decreased dose to multiple critical structures by up to 33%. [57]", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy. Traditionally, treatment fields for\u00a0nasopharyngeal carcinoma encompassed the entire (bilateral) nasopharynx, along with the at-risk nodal basins of the retropharynx and bilateral neck. The fossa of Rosenmuller is the most common site of origin within the nasopharynx, representing over 80% of nasopharyngeal carcinoma cases, with the tumor remaining unilateral in up to 90% of cases even as the tumor expands. [55] [56] Recognizing the potential to reduce radiation dose volumes, the deliberate exclusion of the contralateral nasopharynx and surrounding critical structures in\u00a0the NRG HN001 trial resulted in up to 62% reduction in CTV2 volume and a decreased dose to multiple critical structures by up to 33%. [57]"}
{"id": "article-25574_41", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy", "content": "Nasopharyngeal carcinoma\u00a0presents a high risk of nodal metastasis, often being the primary complaint at the time of diagnosis. Except for stage I disease, the at-risk nodal basins must be treated.\u00a0While the level II (jugulodigastric) nodes were traditionally considered\u00a0the most frequent site of metastasis in nasopharyngeal carcinoma, modern imaging techniques have identified retropharyngeal nodes\u00a0as the\u00a0most common metastatic site. [58] Nodal metastatic progression\u00a0typically follows a stepwise pattern: first, the retropharyngeal notes, then proceeding caudally along the deep cervical nodes to levels III, IV, and V. Level I, the intraparotid nodes, supraclavicular nodes, and level VI were found to be highly low-risk basins in a meta-analysis of over 10,000 nodes. [59]", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy. Nasopharyngeal carcinoma\u00a0presents a high risk of nodal metastasis, often being the primary complaint at the time of diagnosis. Except for stage I disease, the at-risk nodal basins must be treated.\u00a0While the level II (jugulodigastric) nodes were traditionally considered\u00a0the most frequent site of metastasis in nasopharyngeal carcinoma, modern imaging techniques have identified retropharyngeal nodes\u00a0as the\u00a0most common metastatic site. [58] Nodal metastatic progression\u00a0typically follows a stepwise pattern: first, the retropharyngeal notes, then proceeding caudally along the deep cervical nodes to levels III, IV, and V. Level I, the intraparotid nodes, supraclavicular nodes, and level VI were found to be highly low-risk basins in a meta-analysis of over 10,000 nodes. [59]"}
{"id": "article-25574_42", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy", "content": "An important caveat relates to level Ib. Sparing the submandibular glands to minimize xerostomia is often desirable, mainly if level I is low-risk. If the level II nodes are greater than 2 cm or display extracapsular spread, the level Ib nodes are considered higher risk and should be included in the treatment fields. [60] Current international guidelines recommend a total dose of 70 Gy to high-risk clinical target volume and 50 to 60 Gy to low- and intermediate-risk clinical target volume. [51]", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy. An important caveat relates to level Ib. Sparing the submandibular glands to minimize xerostomia is often desirable, mainly if level I is low-risk. If the level II nodes are greater than 2 cm or display extracapsular spread, the level Ib nodes are considered higher risk and should be included in the treatment fields. [60] Current international guidelines recommend a total dose of 70 Gy to high-risk clinical target volume and 50 to 60 Gy to low- and intermediate-risk clinical target volume. [51]"}
{"id": "article-25574_43", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy", "content": "In cases of treatment failures, most local failures occurred within the high-dose fields, prompting interest in de-escalation to\u00a0reduce\u00a0radiation therapy-associated morbidity to surrounding structures. [61] This is an area of active research, with trials demonstrating encouraging short-term results after gradient dosing in dose prescription, as opposed to the more traditional 2-tiered dosing. [62] Induction chemotherapy has also been employed as a method to\u00a0identify tumors responsive to de-escalation,\u00a0especially in the pediatric population, where the long-term consequences of facial radiation are significant. Promising results have been reported in clinical trials, such as the NPC-2003-GPOH/DCOG trial, using various induction chemotherapy protocols for de-escalation, with 5-year, event-free survival rates of 77% to 91% reported after de-escalation to 45-68 Gy. [63]", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Radiation Therapy. In cases of treatment failures, most local failures occurred within the high-dose fields, prompting interest in de-escalation to\u00a0reduce\u00a0radiation therapy-associated morbidity to surrounding structures. [61] This is an area of active research, with trials demonstrating encouraging short-term results after gradient dosing in dose prescription, as opposed to the more traditional 2-tiered dosing. [62] Induction chemotherapy has also been employed as a method to\u00a0identify tumors responsive to de-escalation,\u00a0especially in the pediatric population, where the long-term consequences of facial radiation are significant. Promising results have been reported in clinical trials, such as the NPC-2003-GPOH/DCOG trial, using various induction chemotherapy protocols for de-escalation, with 5-year, event-free survival rates of 77% to 91% reported after de-escalation to 45-68 Gy. [63]"}
{"id": "article-25574_44", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Chemotherapy", "content": "A phase III intergroup study\u00a0demonstrated a statistically significant improvement in progression-free survival and overall survival for patients with\u00a0stage III and locally advanced stage IV nasopharyngeal carcinoma when treated with bimodality\u00a0therapy comprising radiation therapy with systemic chemotherapy. [64] [65] [66] These early studies have formed the\u00a0foundation\u00a0of current international treatment guidelines for advanced-stage nasopharyngeal carcinoma. The most current international recommendations, jointly issued by the American Society of Clinical Oncology and the Chinese Society of Clinical Oncology, advocate the following approaches: For patients with stage II disease, the role of chemotherapy depends on the status of the lymph nodes. In T2N0 disease, chemotherapy is not routinely offered. In T1-2N1 disease, concurrent chemoradiation therapy is recommended.", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Chemotherapy. A phase III intergroup study\u00a0demonstrated a statistically significant improvement in progression-free survival and overall survival for patients with\u00a0stage III and locally advanced stage IV nasopharyngeal carcinoma when treated with bimodality\u00a0therapy comprising radiation therapy with systemic chemotherapy. [64] [65] [66] These early studies have formed the\u00a0foundation\u00a0of current international treatment guidelines for advanced-stage nasopharyngeal carcinoma. The most current international recommendations, jointly issued by the American Society of Clinical Oncology and the Chinese Society of Clinical Oncology, advocate the following approaches: For patients with stage II disease, the role of chemotherapy depends on the status of the lymph nodes. In T2N0 disease, chemotherapy is not routinely offered. In T1-2N1 disease, concurrent chemoradiation therapy is recommended."}
{"id": "article-25574_45", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Chemotherapy", "content": "For patients with T3N0 disease, concurrent chemoradiation therapy\u00a0is recommended, and\u00a0induction chemotherapy or adjuvant chemotherapy may be offered. For patients with all other stage III-IVA disease, concurrent chemoradiation therapy should be administered,\u00a0along with\u00a0either induction or adjuvant chemotherapy. [67] Concurrent chemotherapeutic for nasopharyngeal carcinoma typically involves the use of cisplatin, which remains the agent of choice. The administration of cisplatin varies as follows: Patients without contraindications, cisplatin is ideally administered concurrently with radiation therapy as follows: [68] [69] [70] [71] [72] Weekly 40 mg/m 2 for 7 doses or, Tri-weekly 100 mg/m 2 for 3 doses Patients with contraindications to cisplatin may use the following treatment options: [67] Carboplatin AUC5-6 triweekly Nedaplatin 100 mg/m 2 triweekly Oxaliplatin 70 mg/m 2", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Chemotherapy. For patients with T3N0 disease, concurrent chemoradiation therapy\u00a0is recommended, and\u00a0induction chemotherapy or adjuvant chemotherapy may be offered. For patients with all other stage III-IVA disease, concurrent chemoradiation therapy should be administered,\u00a0along with\u00a0either induction or adjuvant chemotherapy. [67] Concurrent chemotherapeutic for nasopharyngeal carcinoma typically involves the use of cisplatin, which remains the agent of choice. The administration of cisplatin varies as follows: Patients without contraindications, cisplatin is ideally administered concurrently with radiation therapy as follows: [68] [69] [70] [71] [72] Weekly 40 mg/m 2 for 7 doses or, Tri-weekly 100 mg/m 2 for 3 doses Patients with contraindications to cisplatin may use the following treatment options: [67] Carboplatin AUC5-6 triweekly Nedaplatin 100 mg/m 2 triweekly Oxaliplatin 70 mg/m 2"}
{"id": "article-25574_46", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Chemotherapy", "content": "If\u00a0a patient\u00a0cannot\u00a0tolerate any platinum-based chemotherapy, concurrent use of capecitabine, tegafur, and 5-fluorouracil (5-FU) radiation therapy is also an option. [73]", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Chemotherapy. If\u00a0a patient\u00a0cannot\u00a0tolerate any platinum-based chemotherapy, concurrent use of capecitabine, tegafur, and 5-fluorouracil (5-FU) radiation therapy is also an option. [73]"}
{"id": "article-25574_47", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Induction chemotherapeutic agents:", "content": "Platinum-based agents\u00a0are recommended for all\u00a0patients\u00a0undergoing\u00a0induction chemotherapy, with\u00a0a notable increase in overall survival\u00a0documented in a landmark phase II study in 2009. This study showed an improvement in overall survival from 68% to 94% with the addition of\u00a02 cycles of docetaxel. [74] Current recommended induction regimens include: [75] [76] [77] [78] Docetaxel 60 to 75 mg/m 2 on day 1; cisplatin 60 to 75 mg/m 2 on day 1; 5-FU 600 to 750 mg/m 2 per day, continuous infusion on days 1 to 5 Gemcitabine 1000 mg/m 2 on day 1 and day 8; cisplatin 80 mg/m 2 on day 1 Cisplatin 80 to 100mg/m 2 on day 1; 5-FU 800 to 1000 mg/m 2 per day, continuous infusion on days 1 to 5 Cisplatin 100 mg/m 2 on day 1; capecitabine 2000 mg/m 2 per day on days 1 to 14 Docetaxel 75 mg/m 2 on day 1; cisplatin 75mg/m 2 on day 1.", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Induction chemotherapeutic agents:. Platinum-based agents\u00a0are recommended for all\u00a0patients\u00a0undergoing\u00a0induction chemotherapy, with\u00a0a notable increase in overall survival\u00a0documented in a landmark phase II study in 2009. This study showed an improvement in overall survival from 68% to 94% with the addition of\u00a02 cycles of docetaxel. [74] Current recommended induction regimens include: [75] [76] [77] [78] Docetaxel 60 to 75 mg/m 2 on day 1; cisplatin 60 to 75 mg/m 2 on day 1; 5-FU 600 to 750 mg/m 2 per day, continuous infusion on days 1 to 5 Gemcitabine 1000 mg/m 2 on day 1 and day 8; cisplatin 80 mg/m 2 on day 1 Cisplatin 80 to 100mg/m 2 on day 1; 5-FU 800 to 1000 mg/m 2 per day, continuous infusion on days 1 to 5 Cisplatin 100 mg/m 2 on day 1; capecitabine 2000 mg/m 2 per day on days 1 to 14 Docetaxel 75 mg/m 2 on day 1; cisplatin 75mg/m 2 on day 1."}
{"id": "article-25574_48", "title": "Nasopharyngeal Cancer -- Treatment / Management -- Adjuvant chemotherapeutic agents:", "content": "Platinum-based agents\u00a0are essential\u00a0in all patients receiving adjuvant chemotherapy for\u00a0nasopharyngeal carcinoma unless contraindicated. [68] The preferred regimen is: Cisplatin 80 mg/m 2 on day 1 or 20 mg/m 2 on days 1 to 5; 5-FU 1000 mg/m 2 per day, continuous infusion on days 1 to 4 or 800 mg/m 2 per day, continuous infusion on days 1 to 5. This is to be administered every\u00a04 weeks for 3 cycles. [79] [71] Carboplatin may be used if cisplatin is intolerable and can be combined with 5-FU. [80] Enrolling in a clinical trial is recommended, if possible, in the presence of a significant contraindication to platinum-based agents. Nonplatinum-based agents in\u00a0nasopharyngeal\u00a0treatment remain experimental and should not be routinely offered. [67]", "contents": "Nasopharyngeal Cancer -- Treatment / Management -- Adjuvant chemotherapeutic agents:. Platinum-based agents\u00a0are essential\u00a0in all patients receiving adjuvant chemotherapy for\u00a0nasopharyngeal carcinoma unless contraindicated. [68] The preferred regimen is: Cisplatin 80 mg/m 2 on day 1 or 20 mg/m 2 on days 1 to 5; 5-FU 1000 mg/m 2 per day, continuous infusion on days 1 to 4 or 800 mg/m 2 per day, continuous infusion on days 1 to 5. This is to be administered every\u00a04 weeks for 3 cycles. [79] [71] Carboplatin may be used if cisplatin is intolerable and can be combined with 5-FU. [80] Enrolling in a clinical trial is recommended, if possible, in the presence of a significant contraindication to platinum-based agents. Nonplatinum-based agents in\u00a0nasopharyngeal\u00a0treatment remain experimental and should not be routinely offered. [67]"}
{"id": "article-25574_49", "title": "Nasopharyngeal Cancer -- Differential Diagnosis", "content": "Several conditions may present with symptoms similar to nasopharyngeal carcinoma, making differential diagnosis crucial. Some of the conditions to consider include: Enlarged adenoids/HIV-associated lymphatic hyperplasia Antrochoanal polyp Inverting\u00a0 papilloma Vascular malformation Malignancy Nasal polyposis Infectious mononucleosis Non-Hodgkin lymphoma Sarcoma Adenocarcinoma Wegener granulomatosis Rhinosporidiosis", "contents": "Nasopharyngeal Cancer -- Differential Diagnosis. Several conditions may present with symptoms similar to nasopharyngeal carcinoma, making differential diagnosis crucial. Some of the conditions to consider include: Enlarged adenoids/HIV-associated lymphatic hyperplasia Antrochoanal polyp Inverting\u00a0 papilloma Vascular malformation Malignancy Nasal polyposis Infectious mononucleosis Non-Hodgkin lymphoma Sarcoma Adenocarcinoma Wegener granulomatosis Rhinosporidiosis"}
{"id": "article-25574_50", "title": "Nasopharyngeal Cancer -- Prognosis", "content": "The prognosis of nasopharyngeal carcinoma is closely linked to\u00a0its stage at presentation. A more favorable survival outcome\u00a0is observed in stage I disease,\u00a0whereas\u00a0stage IV disease is associated with the poorest prognosis. The overall relative 5-year survival rate for stage I\u00a0nasopharyngeal carcinoma\u00a0is 82%.\u00a0However, for\u00a0stage II disease, this\u00a0rate decreases\u00a0to 72%, and in the case of stage IV disease, the 5-year relative survival rate drops\u00a0further to 49% [81] [82] .", "contents": "Nasopharyngeal Cancer -- Prognosis. The prognosis of nasopharyngeal carcinoma is closely linked to\u00a0its stage at presentation. A more favorable survival outcome\u00a0is observed in stage I disease,\u00a0whereas\u00a0stage IV disease is associated with the poorest prognosis. The overall relative 5-year survival rate for stage I\u00a0nasopharyngeal carcinoma\u00a0is 82%.\u00a0However, for\u00a0stage II disease, this\u00a0rate decreases\u00a0to 72%, and in the case of stage IV disease, the 5-year relative survival rate drops\u00a0further to 49% [81] [82] ."}
{"id": "article-25574_51", "title": "Nasopharyngeal Cancer -- Prognosis", "content": "After initial treatment,\u00a0patients should maintain regular follow-ups with their oncologist for cancer surveillance. This involves\u00a0physical examinations, nasal endoscopy, and\u00a0possibly\u00a0serum labwork for EBV DNA and thyroid function due to the risk of post-radiotherapy hypothyroidism. Detectable EBV DNA levels post-treatment are associated with an unfavorable prognosis, making it an established negative prognostic marker for nasopharyngeal carcinoma. [83] However, the\u00a0use\u00a0of circulating EBV DNA in monitoring after chemoradiotherapy for\u00a0nasopharyngeal carcinoma remains under investigation. [84]", "contents": "Nasopharyngeal Cancer -- Prognosis. After initial treatment,\u00a0patients should maintain regular follow-ups with their oncologist for cancer surveillance. This involves\u00a0physical examinations, nasal endoscopy, and\u00a0possibly\u00a0serum labwork for EBV DNA and thyroid function due to the risk of post-radiotherapy hypothyroidism. Detectable EBV DNA levels post-treatment are associated with an unfavorable prognosis, making it an established negative prognostic marker for nasopharyngeal carcinoma. [83] However, the\u00a0use\u00a0of circulating EBV DNA in monitoring after chemoradiotherapy for\u00a0nasopharyngeal carcinoma remains under investigation. [84]"}
{"id": "article-25574_52", "title": "Nasopharyngeal Cancer -- Prognosis", "content": "Currently, the standard of care for posttreatment surveillance\u00a0includes physical examination and nasal endoscopy,\u00a0with\u00a0the\u00a0optimal\u00a0timeline and frequency being\u00a0a subject of debate.\u00a0Many experts\u00a0recommend frequent screening\u00a0in the first 12 to 24 months post-treatment, such as every 3 months. This\u00a0may be extended\u00a0to every 4 to 6 months\u00a0during years 3 to 5 post-treatment and annually after that. [85]", "contents": "Nasopharyngeal Cancer -- Prognosis. Currently, the standard of care for posttreatment surveillance\u00a0includes physical examination and nasal endoscopy,\u00a0with\u00a0the\u00a0optimal\u00a0timeline and frequency being\u00a0a subject of debate.\u00a0Many experts\u00a0recommend frequent screening\u00a0in the first 12 to 24 months post-treatment, such as every 3 months. This\u00a0may be extended\u00a0to every 4 to 6 months\u00a0during years 3 to 5 post-treatment and annually after that. [85]"}
{"id": "article-25574_53", "title": "Nasopharyngeal Cancer -- Prognosis", "content": "Most centers conduct a posttreatment PET-CT scan 3 months after completing radiotherapy, followed by a 1-year posttreatment PET-CT if the initial scan is normal. [86] If\u00a0both scans\u00a0are negative, further surveillance imaging may not be recommended in nonendemic areas. [87] [88] However, these guidelines may vary, and individualized approaches may be considered based on patient-specific factors and evolving research.", "contents": "Nasopharyngeal Cancer -- Prognosis. Most centers conduct a posttreatment PET-CT scan 3 months after completing radiotherapy, followed by a 1-year posttreatment PET-CT if the initial scan is normal. [86] If\u00a0both scans\u00a0are negative, further surveillance imaging may not be recommended in nonendemic areas. [87] [88] However, these guidelines may vary, and individualized approaches may be considered based on patient-specific factors and evolving research."}
{"id": "article-25574_54", "title": "Nasopharyngeal Cancer -- Complications", "content": "Nasopharyngeal carcinoma and its treatment can lead to various complications. Here are some potential complications associated with nasopharyngeal carcinoma:", "contents": "Nasopharyngeal Cancer -- Complications. Nasopharyngeal carcinoma and its treatment can lead to various complications. Here are some potential complications associated with nasopharyngeal carcinoma:"}
{"id": "article-25574_55", "title": "Nasopharyngeal Cancer -- Complications -- Treatment-Related Complications", "content": "Radiation therapy adverse effects: Radiation therapy can cause\u00a0adverse effects such as mucositis, xerostomia (dry mouth), radiation dermatitis, and fatigue. Chemotherapy adverse effects: Chemotherapy may lead to nausea, vomiting, fatigue, hair loss, and increased susceptibility to infections. Immunosuppression: Cancer and its treatments can weaken the immune system, making individuals more susceptible to infections.", "contents": "Nasopharyngeal Cancer -- Complications -- Treatment-Related Complications. Radiation therapy adverse effects: Radiation therapy can cause\u00a0adverse effects such as mucositis, xerostomia (dry mouth), radiation dermatitis, and fatigue. Chemotherapy adverse effects: Chemotherapy may lead to nausea, vomiting, fatigue, hair loss, and increased susceptibility to infections. Immunosuppression: Cancer and its treatments can weaken the immune system, making individuals more susceptible to infections."}
{"id": "article-25574_56", "title": "Nasopharyngeal Cancer -- Complications -- Long-Term Adverse\u00a0Effects", "content": "Xerostomia: A dry mouth due to reduced salivary gland function, often caused by radiation therapy, can lead to difficulties in swallowing and speaking and an increased risk of dental issues. Hearing loss: Depending on the location and extent of the tumor, hearing loss may occur, primarily if the cancer affects the nearby structures. Cognitive issues: Radiation therapy to the head and neck region may affect cognitive function.", "contents": "Nasopharyngeal Cancer -- Complications -- Long-Term Adverse\u00a0Effects. Xerostomia: A dry mouth due to reduced salivary gland function, often caused by radiation therapy, can lead to difficulties in swallowing and speaking and an increased risk of dental issues. Hearing loss: Depending on the location and extent of the tumor, hearing loss may occur, primarily if the cancer affects the nearby structures. Cognitive issues: Radiation therapy to the head and neck region may affect cognitive function."}
{"id": "article-25574_57", "title": "Nasopharyngeal Cancer -- Complications -- Metastasis and Recurrence", "content": "Distant metastasis:\u00a0Nasopharyngeal carcinoma\u00a0has a propensity to metastasize to distant organs. Local recurrence: Despite treatment, local tumor recurrence may occur, necessitating further interventions.", "contents": "Nasopharyngeal Cancer -- Complications -- Metastasis and Recurrence. Distant metastasis:\u00a0Nasopharyngeal carcinoma\u00a0has a propensity to metastasize to distant organs. Local recurrence: Despite treatment, local tumor recurrence may occur, necessitating further interventions."}
{"id": "article-25574_58", "title": "Nasopharyngeal Cancer -- Complications -- Secondary Cancers", "content": "Treatment-related secondary cancers: Long-term survivors of\u00a0nasopharyngeal carcinoma may be at a higher risk of developing secondary cancers, often related to the treatment received.", "contents": "Nasopharyngeal Cancer -- Complications -- Secondary Cancers. Treatment-related secondary cancers: Long-term survivors of\u00a0nasopharyngeal carcinoma may be at a higher risk of developing secondary cancers, often related to the treatment received."}
{"id": "article-25574_59", "title": "Nasopharyngeal Cancer -- Deterrence and Patient Education", "content": "Deterrence and patient education for nasopharyngeal carcinoma encompasses a range of strategies aimed at preventing the development of the disease and informing individuals about various aspects related to\u00a0nasopharyngeal carcinoma. Education efforts emphasize key risk factors, such as EBV infection, family history, and geographic predispositions, encouraging individuals to avoid known risk factors like tobacco use and excessive alcohol consumption.", "contents": "Nasopharyngeal Cancer -- Deterrence and Patient Education. Deterrence and patient education for nasopharyngeal carcinoma encompasses a range of strategies aimed at preventing the development of the disease and informing individuals about various aspects related to\u00a0nasopharyngeal carcinoma. Education efforts emphasize key risk factors, such as EBV infection, family history, and geographic predispositions, encouraging individuals to avoid known risk factors like tobacco use and excessive alcohol consumption."}
{"id": "article-25574_60", "title": "Nasopharyngeal Cancer -- Deterrence and Patient Education", "content": "Lifestyle modifications, including a healthy diet and regular physical activity, are promoted for risk reduction. Emphasis is placed on the significance of early detection through regular health check-ups and screenings, with information about\u00a0nasopharyngeal carcinoma symptoms provided to the public. Considering the increased risk in specific regions and among certain ethnic groups, education addresses geographic and ethnic considerations, urging vigilance and prompt medical attention in high-risk populations.", "contents": "Nasopharyngeal Cancer -- Deterrence and Patient Education. Lifestyle modifications, including a healthy diet and regular physical activity, are promoted for risk reduction. Emphasis is placed on the significance of early detection through regular health check-ups and screenings, with information about\u00a0nasopharyngeal carcinoma symptoms provided to the public. Considering the increased risk in specific regions and among certain ethnic groups, education addresses geographic and ethnic considerations, urging vigilance and prompt medical attention in high-risk populations."}
{"id": "article-25574_61", "title": "Nasopharyngeal Cancer -- Deterrence and Patient Education", "content": "Awareness about EBV infection and hygiene practices to reduce transmission is highlighted, alongside genetic counseling services for those with a family history of nasopharyngeal carcinoma.\u00a0Encouraging regular health check-ups and providing information on available treatment options, potential\u00a0adverse effects, and prognosis are integral aspects.", "contents": "Nasopharyngeal Cancer -- Deterrence and Patient Education. Awareness about EBV infection and hygiene practices to reduce transmission is highlighted, alongside genetic counseling services for those with a family history of nasopharyngeal carcinoma.\u00a0Encouraging regular health check-ups and providing information on available treatment options, potential\u00a0adverse effects, and prognosis are integral aspects."}
{"id": "article-25574_62", "title": "Nasopharyngeal Cancer -- Pearls and Other Issues", "content": "Key facts to keep in mind about nasopharyngeal carcinoma are as follows: Nasopharyngeal carcinoma\u00a0has a distinct geographic distribution, with a higher incidence in Southeast Asia, particularly in regions like China. EBV infection is strongly associated with nasopharyngeal carcinoma, especially in endemic areas. Genetic factors, family history, and environmental exposures, such as consumption of preserved foods containing nitrosamines, are implicated. Smoking and alcohol use may be risk factors in nonendemic areas. Nasopharyngeal carcinoma\u00a0is classified into\u00a03 histological subtypes by the WHO: keratinizing squamous cell carcinoma (Type 1), differentiated nonkeratinizing carcinoma (Type 2), and undifferentiated carcinoma (Type 3). Symptoms may include a painless neck mass, otitis media, nasal obstruction, and other head and neck-related symptoms. Diagnosis often occurs at an advanced stage due to the anatomical location of the nasopharynx.", "contents": "Nasopharyngeal Cancer -- Pearls and Other Issues. Key facts to keep in mind about nasopharyngeal carcinoma are as follows: Nasopharyngeal carcinoma\u00a0has a distinct geographic distribution, with a higher incidence in Southeast Asia, particularly in regions like China. EBV infection is strongly associated with nasopharyngeal carcinoma, especially in endemic areas. Genetic factors, family history, and environmental exposures, such as consumption of preserved foods containing nitrosamines, are implicated. Smoking and alcohol use may be risk factors in nonendemic areas. Nasopharyngeal carcinoma\u00a0is classified into\u00a03 histological subtypes by the WHO: keratinizing squamous cell carcinoma (Type 1), differentiated nonkeratinizing carcinoma (Type 2), and undifferentiated carcinoma (Type 3). Symptoms may include a painless neck mass, otitis media, nasal obstruction, and other head and neck-related symptoms. Diagnosis often occurs at an advanced stage due to the anatomical location of the nasopharynx."}
{"id": "article-25574_63", "title": "Nasopharyngeal Cancer -- Pearls and Other Issues", "content": "Diagnosis is confirmed through biopsy, often via endoscopic procedures. Imaging studies such as CT and MRI are used for staging and treatment planning. EBV DNA testing may be utilized for screening and monitoring. Chemotherapy is often used in combination with radiation for more advanced stages. Surgery is rarely employed due to the challenging anatomical location of the nasopharynx. Prognosis is stage-dependent, with Stage I having a more favorable outlook compared to Stage IV.", "contents": "Nasopharyngeal Cancer -- Pearls and Other Issues. Diagnosis is confirmed through biopsy, often via endoscopic procedures. Imaging studies such as CT and MRI are used for staging and treatment planning. EBV DNA testing may be utilized for screening and monitoring. Chemotherapy is often used in combination with radiation for more advanced stages. Surgery is rarely employed due to the challenging anatomical location of the nasopharynx. Prognosis is stage-dependent, with Stage I having a more favorable outlook compared to Stage IV."}
{"id": "article-25574_64", "title": "Nasopharyngeal Cancer -- Enhancing Healthcare Team Outcomes", "content": "Collaboration among healthcare professionals is paramount in providing comprehensive, patient-centered care for nasopharyngeal carcinoma. Physicians and advanced practitioners should demonstrate proficiency in diagnosis, staging, and treatment planning, incorporating surgical skills and expertise in chemotherapy or immunotherapy. Nurses are vital in supportive care, symptom management, and patient education, while pharmacists ensure safe medication administration.", "contents": "Nasopharyngeal Cancer -- Enhancing Healthcare Team Outcomes. Collaboration among healthcare professionals is paramount in providing comprehensive, patient-centered care for nasopharyngeal carcinoma. Physicians and advanced practitioners should demonstrate proficiency in diagnosis, staging, and treatment planning, incorporating surgical skills and expertise in chemotherapy or immunotherapy. Nurses are vital in supportive care, symptom management, and patient education, while pharmacists ensure safe medication administration."}
{"id": "article-25574_65", "title": "Nasopharyngeal Cancer -- Enhancing Healthcare Team Outcomes", "content": "Regular interdisciplinary tumor board meetings facilitate collective decision-making, while an ethical approach involves informed consent and cultural competence. Effective interprofessional communication is maintained through regular team meetings and clear patient handovers, and care coordination involves patient navigation services and post-treatment follow-up plans. This collaborative approach optimizes patient outcomes, enhances safety, and improves the quality of care for individuals with nasopharyngeal carcinoma.", "contents": "Nasopharyngeal Cancer -- Enhancing Healthcare Team Outcomes. Regular interdisciplinary tumor board meetings facilitate collective decision-making, while an ethical approach involves informed consent and cultural competence. Effective interprofessional communication is maintained through regular team meetings and clear patient handovers, and care coordination involves patient navigation services and post-treatment follow-up plans. This collaborative approach optimizes patient outcomes, enhances safety, and improves the quality of care for individuals with nasopharyngeal carcinoma."}
{"id": "article-25574_66", "title": "Nasopharyngeal Cancer -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Nasopharyngeal Cancer -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}